{"disease":{"id":"sclerotic-graft-versus-host-disease","name":"sclerotic graft versus host disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03954236","title":"Study of the Safety and Efficacy of Ruxolitinib Cream for Non-Sclerotic Chronic Cutaneous Graft-Versus-Host Disease","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":24,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":true},{"nct_id":"NCT00702689","title":"Imatinib Mesylate to Treat Skin Changes in Patients With Chronic Graft-Versus-Host Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT04954573","title":"Study on the Treatment With Water-filtered Infrared-A (wIRA) Radiation in Patients With Morphea and Sclerotic Graft-versus-host Disease","phase":"NA","overall_status":"TERMINATED","enrollment_count":11,"lead_sponsor_name":"Medical University of Graz","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}